Hyatt Regency Huntington Beach Resort & Spa, Huntington Beach, CA
IBC's Biopharmaceutical Development & Production Week provides you with practical Methods and techniques to help you navigate the development, production and regulatory challenges of an emerging wave of new Molecules progressing through the biopharmaceutical pipeline.
TIDES is the only event with full coverage of discovery, development and manufacturing of oligonucleotide and peptide therapeutics. Sessions cover CMC manufacturing of peptide and oligonucleotide-based therapeutics in an in-depth manner, together with complete coverage of drug discovery and development.
This conference is the industry's most innovative and comprehensive conference for sharing best practices and new ideas to accelerate the discovery, engineering and development of alternative scaffolds and novel protein therapeutics to create differentiated drugs.
This conference focuses on discovery, design, development and CMC manufacturing issues of antibody-drug conjugates and many other types of bioconjugates, in order to facilitate information sharing and help companies move their programs forward.
IBC's Antibody Engineering & Therapeutics conference is an invaluable resource for your research programs. Attending these meetings means getting important updates from the early stage work of leading academic researchers and tracking the progress of companies advancing antibody therapeutics through clinical development. Covering both cutting-edge developments in the basic science of antibody engineering and clinical/preclinical updates of therapeutic antibodies in development.